Statistical analysis was conducted using SPSS version 14.0
PubMed laboratory research record [PMID: 195974] PubMed record related to this compound for laboratory literature review
The clinical need must be considered in addition to any potential adverse outcomes for the infant
Bone microstructure: OVX control group: The number of bone trabeculae decreased by 30%, the thickness decreased by 25%, and the gap increased by 40%
This page is intended to provide educational, research-use-only information about 5-Amino-1MQ capsules, laboratory compound handling, research material quality control, HPLC analysis, LC-MS verification, and related research compound resources
Can I Combine B12 Injections with Other Treatments